Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

"Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases.

Meirelles GV, Perez AM, de Souza EE, Basei FL, Papa PF, Melo Hanchuk TD, Cardoso VB, Kobarg J.

World J Biol Chem. 2014 May 26;5(2):141-60. doi: 10.4331/wjbc.v5.i2.141. Review.

PMID:
24921005
[PubMed]
Free PMC Article
2.

A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice.

Hu Y, Zheng M, Gali R, Tian Z, Topal Görgün G, Munshi NC, Mitsiades CS, Anderson KC.

Blood Cancer J. 2013 Nov 1;3:e156. doi: 10.1038/bcj.2013.53.

PMID:
24185503
[PubMed]
Free PMC Article
3.

The effects of promoter methylation on downregulation of DAZAP2 in multiple myeloma cell lines.

Luo SQ, Hu JP, Qu Q, Li J, Ren W, Zhang JM, Zhong Y, Hu WX.

PLoS One. 2012;7(7):e40475. doi: 10.1371/journal.pone.0040475. Epub 2012 Jul 9.

PMID:
22792345
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Clonal competition with alternating dominance in multiple myeloma.

Keats JJ, Chesi M, Egan JB, Garbitt VM, Palmer SE, Braggio E, Van Wier S, Blackburn PR, Baker AS, Dispenzieri A, Kumar S, Rajkumar SV, Carpten JD, Barrett M, Fonseca R, Stewart AK, Bergsagel PL.

Blood. 2012 Aug 2;120(5):1067-76. doi: 10.1182/blood-2012-01-405985. Epub 2012 Apr 12.

PMID:
22498740
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prediction of cytogenetic abnormalities with gene expression profiles.

Zhou Y, Zhang Q, Stephens O, Heuck CJ, Tian E, Sawyer JR, Cartron-Mizeracki MA, Qu P, Keller J, Epstein J, Barlogie B, Shaughnessy JD Jr.

Blood. 2012 May 24;119(21):e148-50. doi: 10.1182/blood-2011-10-388702. Epub 2012 Apr 10.

PMID:
22496154
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival.

Debes Marun CS, Belch AR, Pilarski LM.

Am J Hematol. 2012 Jun;87(6):579-87. doi: 10.1002/ajh.23194. Epub 2012 Apr 12.

PMID:
22495885
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3.

Shaughnessy JD Jr, Qu P, Usmani S, Heuck CJ, Zhang Q, Zhou Y, Tian E, Hanamura I, van Rhee F, Anaissie E, Epstein J, Nair B, Stephens O, Williams R, Waheed S, Alsayed Y, Crowley J, Barlogie B.

Blood. 2011 Sep 29;118(13):3512-24. doi: 10.1182/blood-2010-12-328252. Epub 2011 May 31.

PMID:
21628408
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

Zhou Y, Chen L, Barlogie B, Stephens O, Wu X, Williams DR, Cartron MA, van Rhee F, Nair B, Waheed S, Pineda-Roman M, Alsayed Y, Anaissie E, Shaughnessy JD Jr.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7904-9. doi: 10.1073/pnas.0908441107. Epub 2010 Apr 12.

PMID:
20385818
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology.

Hanlon K, Harries LW, Ellard S, Rudin CE.

J Mol Diagn. 2009 Sep;11(5):450-7. doi: 10.2353/jmoldx.2009.090027. Epub 2009 Jul 30.

PMID:
19644022
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.

O'Neal J, Gao F, Hassan A, Monahan R, Barrios S, Kilimann MW, Lee I, Chng WJ, Vij R, Tomasson MH.

Exp Hematol. 2009 Feb;37(2):234-44. doi: 10.1016/j.exphem.2008.10.014. Erratum in: Exp Hematol. 2009 Apr;37(4):532. Kilimann, Manfred W [added].

PMID:
19135901
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.

Shammas MA, Shmookler Reis RJ, Koley H, Batchu RB, Li C, Munshi NC.

Blood. 2009 Mar 5;113(10):2290-7. doi: 10.1182/blood-2007-05-089193. Epub 2008 Dec 2.

PMID:
19050310
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Suppression of abnormal karyotype predicts superior survival in multiple myeloma.

Arzoumanian V, Hoering A, Sawyer J, van Rhee F, Bailey C, Gurley J, Shaughnessy JD Jr, Anaissie E, Crowley J, Barlogie B.

Leukemia. 2008 Apr;22(4):850-5. doi: 10.1038/sj.leu.2405091. Epub 2008 Jan 17.

PMID:
18200039
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic events in the pathogenesis of multiple myeloma.

Chng WJ, Glebov O, Bergsagel PL, Kuehl WM.

Best Pract Res Clin Haematol. 2007 Dec;20(4):571-96. Review.

PMID:
18070707
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD.

Lerner M, Corcoran M, Cepeda D, Nielsen ML, Zubarev R, Pontén F, Uhlén M, Hober S, Grandér D, Sangfelt O.

Mol Biol Cell. 2007 May;18(5):1670-82. Epub 2007 Feb 21.

PMID:
17314412
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

Hanamura I, Stewart JP, Huang Y, Zhan F, Santra M, Sawyer JR, Hollmig K, Zangarri M, Pineda-Roman M, van Rhee F, Cavallo F, Burington B, Crowley J, Tricot G, Barlogie B, Shaughnessy JD Jr.

Blood. 2006 Sep 1;108(5):1724-32. Epub 2006 May 16.

PMID:
16705089
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A practical approach to the detection of prognostically significant genomic aberrations in multiple myeloma.

Chen Z, Issa B, Huang S, Aston E, Xu J, Yu M, Brothman AR, Glenn M.

J Mol Diagn. 2005 Nov;7(5):560-5.

PMID:
16258153
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Molecular aspects of multiple myeloma.

Pratt G.

Mol Pathol. 2002 Oct;55(5):273-83. Review.

PMID:
12354927
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk